Clinical Trial Update: Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes [Phase 2]

View source ↗

Summary

This Phase 2 trial compared two dosing regimens of linagliptin (2.5 mg twice daily vs 5 mg once daily) as add-on therapy to metformin in adults with Type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2011-10-31